Fifty-seven percent of surveyed medtech industry leaders say their organization has realized benefits across functions by implementing or scaling GenAI use cases or “quick wins,” according to a new report from Deloitte.
Titled “Is Generative AI changing the game for medtech?” the report answers resoundingly in the affirmative, pointing to input from 85 medtech company leaders in a survey conducted by...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?